The Impact of High-Flow Nasal Cannula on Olfactory Function.

Sniffin’ sticks test acute respiratory failure high-flow nasal cannula olfactory function oxygen therapy

Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 20 2 2020
medline: 26 2 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

Oxygen therapy provided via high-flow nasal cannula (HFNC) improves gas exchange lung compliance and results in increased lung expiratory volumes. Previous data indicate that hyperbaric and humid states improve the olfactory thresholds compared to hypobaric and dry conditions. This prospective, observational study aimed to determine the impact of oxygen delivery through HFNC on olfactory function in subjects admitted to the ICU for acute respiratory failure (ARF). 30 subjects who were admitted to the ICU for ARF underwent an olfactory sniff test before and after oxygen therapy with HFNC. Baseline olfactory function of subjects with ARF was also compared against 30 healthy controls. Odor threshold (OT), odor discrimination (OD), odor identification (OI) and global olfactory score (TDI) were recorded for all subjects. The OT, OD, OI, and TDI scores were significantly higher in the control group compared to the baseline scores of the subjects with ARF ( Our results indicate that subjects with ARF had relative olfactory dysfunction compared to healthy controls. These results also suggest that implementation of HFNC to relieve hypoxemia in subjects presenting with ARF can lead to a significant improvement in olfactory function.

Sections du résumé

BACKGROUND BACKGROUND
Oxygen therapy provided via high-flow nasal cannula (HFNC) improves gas exchange lung compliance and results in increased lung expiratory volumes. Previous data indicate that hyperbaric and humid states improve the olfactory thresholds compared to hypobaric and dry conditions. This prospective, observational study aimed to determine the impact of oxygen delivery through HFNC on olfactory function in subjects admitted to the ICU for acute respiratory failure (ARF).
METHODS METHODS
30 subjects who were admitted to the ICU for ARF underwent an olfactory sniff test before and after oxygen therapy with HFNC. Baseline olfactory function of subjects with ARF was also compared against 30 healthy controls. Odor threshold (OT), odor discrimination (OD), odor identification (OI) and global olfactory score (TDI) were recorded for all subjects.
RESULTS RESULTS
The OT, OD, OI, and TDI scores were significantly higher in the control group compared to the baseline scores of the subjects with ARF (
CONCLUSIONS CONCLUSIONS
Our results indicate that subjects with ARF had relative olfactory dysfunction compared to healthy controls. These results also suggest that implementation of HFNC to relieve hypoxemia in subjects presenting with ARF can lead to a significant improvement in olfactory function.

Identifiants

pubmed: 32071128
pii: respcare.07309
doi: 10.4187/respcare.07309
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141-1146

Informations de copyright

Copyright © 2020 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Esra Adiyeke (E)

Department of Anesthesiology and Reanimation, University of Health Sciences, Istanbul, Turkey. esasaladiyeke@gmail.com.
Faculty of Medicine, Sancaktepe Education and Research Hospital, Istanbul, Turkey.

Ozlem Saatci (O)

Department of Otolaryngology and Head and Neck Surgery, University of Health Sciences, Istanbul, Turkey.
Faculty of Medicine, Sancaktepe Education and Research Hospital, Istanbul, Turkey.

Nilufer Coskun (N)

Department of Anesthesiology and Reanimation, University of Health Sciences, Istanbul, Turkey.
Faculty of Medicine, Sancaktepe Education and Research Hospital, Istanbul, Turkey.

Halide F Uludag Kiziltepe (HF)

Department of Anesthesiology and Reanimation, University of Health Sciences, Istanbul, Turkey.
Faculty of Medicine, Süreyyapaşa Education and Research Hospital, Istanbul, Turkey.

Orhan U Dogru (OU)

Department of Anesthesiology and Reanimation, University of Health Sciences, Istanbul, Turkey.
Faculty of Medicine, Sancaktepe Education and Research Hospital, Istanbul, Turkey.

Nurten Bakan (N)

Department of Anesthesiology and Reanimation, University of Health Sciences, Istanbul, Turkey.
Faculty of Medicine, Sancaktepe Education and Research Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH